在血液瘤学中针对CXCR4的治疗术:机遇和挑战
Rudolf Werner1, Alexander Haug2, Christian Buske3
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Nuklearmedizin. Nuclear medicine
|January 8, 2024
概括
在C-X-C基因化学因子受体4 (CXCR4) 疗效测试中,对血液癌症的治疗有希望. 针对CXCR4的成像和放射性干疗法为淋巴瘤提供了新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 核医学就是核医学.
- 血液学 血液学 血液学
背景情况:
- 在各种癌症中,特别是血液性瘤中,C-X-C基因化学酶受体4 (CXCR4) 经常过度表达.
- 这种过度表达为CXCR4导向的治疗方法提供了治疗目标.
研究的目的:
- 总结专家对基于CXCR4的血液瘤学治疗药物的临床实践和未来的意见.
- 评估CXCR4向成像和放射性干疗法 (RLT) 针对特定血液恶性瘤的潜力.
主要方法:
- 从血液瘤学和核医学会议的专家陈述的审查.
- 讨论当前的临床实践和CXCR4治疗术的未来前景.
主要成果:
- 针对CXCR4的[68Ga]Ga-PentixaFor PET/CT成像可以提高边缘区域淋巴瘤的诊断.
- 向CXCR4的RLT显示出在晚期T细胞淋巴瘤中具有抗淋巴瘤功效和骨髓损伤作用.
- 这项研究突出了CXCR4治疗耐药病例中的疗效潜力.
结论:
- 基于CXCR4的治疗药物代表了血液瘤学的创新概念.
- 预期的临床试验对于进一步验证基于CXCR4的成像和RLT的临床试验至关重要.
- 进一步的研究是有必要的,以优化和扩大CXCR4的应用theranostics.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


